Biogen Pharmachem Industries Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|
| Revenue | 1.54 | 1.35 | 0.23 |
| Operating Expense | 0.20 | 0.17 | 0.54 |
| Net Profit | 1.34 | 1.18 | -0.31 |
| Net Profit Margin | 87.01 | 87.41 | -134.78 |
| Earning Per Share | 0.01 | 0.02 | -0.01 |
| EBIDTA | 1.34 | 1.18 | -0.31 |
| Effective Tax Rate | TBA | TBA | TBA |
| Particulars | Jun 2025 |
|---|---|
| Revenue | 1.54 |
| Operating Expense | 0.20 |
| Net Profit | 1.34 |
| Net Profit Margin | 87.01 |
| Earning Per Share | 0.01 |
| EBIDTA | 1.34 |
| Effective Tax Rate | TBA |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Total Revenue Annual | TBA | TBA | TBA |
| Operating Expenses Annual | 1.49 | 0.45 | 0.46 |
| Operating Profit Annual | -0.29 | 1.93 | 0.46 |
| Interest Annual | TBA | TBA | TBA |
| Depreciation | TBA | TBA | TBA |
| Net Profit Annual | -0.29 | 1.93 | 0.46 |
| Tax Annual | TBA | TBA | TBA |
| Particulars | Mar 2025 |
|---|---|
| Total Revenue Annual | TBA |
| Operating Expenses Annual | 1.49 |
| Operating Profit Annual | -0.29 |
| Interest Annual | TBA |
| Depreciation | TBA |
| Net Profit Annual | -0.29 |
| Tax Annual | TBA |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Cash Flow at the Beginning | 0.02 | 0.13 | 0.08 |
| Cash Flow from Operations | -1.08 | 1.94 | 1.70 |
| Cash Flow from Investing | -32.62 | -2.06 | -1.66 |
| Cash Flow from Financing | 35.70 | TBA | TBA |
| Cash Flow at the End | 2.02 | 0.02 | 0.13 |
| Particulars | Mar 2025 |
|---|---|
| Cash Flow at the Beginning | 0.02 |
| Cash Flow from Operations | -1.08 |
| Cash Flow from Investing | -32.62 |
| Cash Flow from Financing | 35.70 |
| Cash Flow at the End | 2.02 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| PBDIT Margin (%) | -24.17 | 81.09 | -21.98 |
| PBIT Margin (%) | -24.17 | 81.09 | -21.98 |
| PBT Margin (%) | -24.17 | 81.09 | -21.98 |
| Net PROFIT Margin (%) | -24.17 | 81.09 | 50.55 |
| Return On Networth / Equity (%) | TBA | 2.96 | -0.34 |
| Return On Networth /Employed (%) | TBA | 2.96 | -0.34 |
| Return On Assets (%) | -0.48 | 3.24 | TBA |
| Total Debt / Equity (X) | TBA | TBA | TBA |
| Asset Turnover Ratio (%) | 0.02 | 0.04 | TBA |
| Particulars | Mar 2025 |
|---|---|
| PBDIT Margin (%) | -24.17 |
| PBIT Margin (%) | -24.17 |
| PBT Margin (%) | -24.17 |
| Net PROFIT Margin (%) | -24.17 |
| Return On Networth / Equity (%) | TBA |
| Return On Networth /Employed (%) | TBA |
| Return On Assets (%) | -0.48 |
| Total Debt / Equity (X) | TBA |
| Asset Turnover Ratio (%) | 0.02 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Fixed Assets Annual | TBA | TBA | TBA |
| Total Current Assets Annual | 2.67 | 0.09 | 0.15 |
| Non Current Assets Annual | 89.35 | 56.73 | 54.67 |
| Total Shareholders Funds Annual | 91.93 | 56.52 | 54.59 |
| Total Assets Annual | 92.02 | 56.82 | 54.83 |
| Particulars | Mar 2025 |
|---|---|
| Fixed Assets Annual | TBA |
| Total Current Assets Annual | 2.67 |
| Non Current Assets Annual | 89.35 |
| Total Shareholders Funds Annual | 91.93 |
| Total Assets Annual | 92.02 |
No Data Availabe
